Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Locke J Bryan

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Hematology/Oncology Clinics of North America|April 3, 2012
Why is my patient anemic?Locke J Bryan, Neil A Zakai
Expert Opinion on Biological Therapy|July 25, 2014
Pidilizumab in the treatment of diffuse large B-cell lymphomaLocke J Bryan, Leo I Gordon
Blood Reviews|September 28, 2014
Blocking tumor escape in hematologic malignancies: the anti-PD-1 strategyLocke J Bryan, Leo I Gordon
Oncology (Williston Park, N.Y.)|June 21, 2015
Releasing the Brake on the Immune System: The PD-1 Strategy for Hematologic MalignanciesLocke J Bryan, Leo I Gordon
Therapeutic Advances in Hematology|April 23, 2021
Update on the role of copanlisib in hematologic malignanciesThuy Le, David Jerel, Locke J Bryan
Oncotargets and Therapy|August 28, 2018
Spotlight on copanlisib and its potential in the treatment of relapsed/refractory follicular lymphoma: evidence to dateFelix A Mensah, Jean-Pierre Blaize, Locke J Bryan
Chest|November 9, 2019
A 43-Year-Old Woman With Hoarseness of Voice and Chest PressureMatthew J Miles, Thomas A Dillard, Locke J Bryan
Thrombosis Research|August 16, 2012
Higher soluble P-selectin is associated with chronic venous insufficiency: the San Diego Population StudyLocke J Bryan, Peter W Callas, Michael H Criqui, et al.
Intractable & Rare Diseases Research|June 21, 2019
Tumefactive fibroinflammatory lesion successfully treated with RituximabJessica L Bishop, Locke J Bryan, Natasha M Savage, et al.
British Journal of Haematology|November 11, 2014
Factors predicting survival in peripheral T-cell lymphoma in the USA: a population-based analysis of 8802 patients in the modern eraAdam M Petrich, Irene B Helenowski, Locke J Bryan, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Hematology/Oncology Clinics of North America|April 3, 2012
Why is my patient anemic?Locke J Bryan, Neil A Zakai
Expert Opinion on Biological Therapy|July 25, 2014
Pidilizumab in the treatment of diffuse large B-cell lymphomaLocke J Bryan, Leo I Gordon
Blood Reviews|September 28, 2014
Blocking tumor escape in hematologic malignancies: the anti-PD-1 strategyLocke J Bryan, Leo I Gordon
Oncology (Williston Park, N.Y.)|June 21, 2015
Releasing the Brake on the Immune System: The PD-1 Strategy for Hematologic MalignanciesLocke J Bryan, Leo I Gordon
Therapeutic Advances in Hematology|April 23, 2021
Update on the role of copanlisib in hematologic malignanciesThuy Le, David Jerel, Locke J Bryan
Oncotargets and Therapy|August 28, 2018
Spotlight on copanlisib and its potential in the treatment of relapsed/refractory follicular lymphoma: evidence to dateFelix A Mensah, Jean-Pierre Blaize, Locke J Bryan
Chest|November 9, 2019
A 43-Year-Old Woman With Hoarseness of Voice and Chest PressureMatthew J Miles, Thomas A Dillard, Locke J Bryan
Thrombosis Research|August 16, 2012
Higher soluble P-selectin is associated with chronic venous insufficiency: the San Diego Population StudyLocke J Bryan, Peter W Callas, Michael H Criqui, et al.
Intractable & Rare Diseases Research|June 21, 2019
Tumefactive fibroinflammatory lesion successfully treated with RituximabJessica L Bishop, Locke J Bryan, Natasha M Savage, et al.
British Journal of Haematology|November 11, 2014
Factors predicting survival in peripheral T-cell lymphoma in the USA: a population-based analysis of 8802 patients in the modern eraAdam M Petrich, Irene B Helenowski, Locke J Bryan, et al.
Pageof 2